Achiko AG Production and Sales Update
21. Dezember 2022 07:42 ET
|
Achiko AG
AptameX™ Gen 2 Covid-19 rapid calibration outperforms Abbott Pan Bio and Clugene’s rapid tests in Indonesia in validation tests.Sample of 20 PCR Positive and 9 Negative samples, indicated a 100% match...
Achiko AG Appoints New Chief Financial Officer
07. Oktober 2022 07:30 ET
|
Achiko AG
ZURICH, Switzerland, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”), a healthcare...
Achiko AG Reports First Half to June 30, 2022 Results and Provides Corporate Update as of September 30, 2022
03. Oktober 2022 07:33 ET
|
Achiko AG
Achiko reports an EBITDA loss of USD $1.9 million, compared to an EBITDA loss of USD $4.6 million for the six months ending June 30, 2021.Focal points of the first half year were completion of a major...
Achiko AG – Investor Briefing
07. Juli 2022 15:22 ET
|
Achiko AG
ZURICH, Switzerland, July 07, 2022 (GLOBE NEWSWIRE) -- Achiko AG (OTCQB: ACHKF, SIX: ACHI, ISIN CH0522213468) (“Achiko”, the “Company”), would like to invite investors and shareholders to a...
Achiko AG Obtains CE Mark for AptameX™ Covid-19 Rapid Test
17. Mai 2022 07:30 ET
|
Achiko AG
Registered AptameX and Has Obtained a CE Mark, Allowing the Product to Be Sold in 27 Countries in the EUAptameX Has Unique Performance Advantages Over Other Rapid Tests Through its Use of DNA...
GPOPlus+ Announces New Chief Operating Officer and Board Member Wayne Smeal
27. Januar 2022 09:15 ET
|
GPO PLUS INC.
LAS VEGAS, NV, Jan. 27, 2022 (GLOBE NEWSWIRE) -- GPO Plus, Inc. (OTCQB: GPOX), a publicly traded company of diversified industry-specific Group Purchasing Organizations (GPOs), today announced Wayne...
Achiko AG Reports Breakthrough Calibration Results for its AptameX™ Covid-19 Rapid Test Technology
14. Januar 2022 07:30 ET
|
Achiko AG
AptameX™ Covid-19 rapid calibration successfully classified 100% of results indicatinga likely > 97% Sensitivity and > 97% Specificity result in the first-generation test kits.Results were...
Achiko Working Towards a Solution for Frequent Global Mass COVID-19 Testing
13. Juli 2021 07:30 ET
|
Achiko AG
ZURICH, Switzerland, July 13, 2021 (GLOBE NEWSWIRE) -- Achiko AG (SWX:ACHI, ISIN CH0522213468) (“Achiko”, the “Company”), a global healthtech company currently developing technologies that seek to...
Clinix Health Announces ‘Turnkey’ Lab-Quality, Mobile Rapid PCR COVID-19 Testing Solutions in Ontario
23. März 2021 07:30 ET
|
Clinix Health
TORONTO, March 23, 2021 (GLOBE NEWSWIRE) -- Clinix Health is pleased to announce it is now providing a range of lab-quality rapid PCR (polymerase chain reaction) testing solutions in Ontario for the...
Achiko Partners with Udayana University for Covid-19 Testing Research in Bali, Indonesia
04. Dezember 2020 07:00 ET
|
Achiko AG
Achiko signed a research agreement with Udayana University’s Research Department to study the practicability of a mass testing approach with Teman Sehat and Gumnuts when availableThe Study will focus...